Immigration Ban: BioPharma Response Varies From Silence To Dissent

While PhRMA, BIO and Pfizer had no response to President Trump’s travel order, Allergan and some smaller firms voiced their objections; PhRMA to meet with Trump on Tuesday.

Passport "denied" stamp

More from Legal & IP

More from Pink Sheet